Proteomics for protein expression profiling in neuroscience

被引:91
作者
Freeman, WM
Hemby, SE
机构
[1] Emory Univ, Sch Med, Yerkes Natl Primate Res Ctr,Neurosci Div, Dept Pharmacol, Atlanta, GA 30329 USA
[2] Emory Univ, Sch Med, Yerkes Natl Primate Res Ctr,Neurosci Div, Dept Psychiat & Behav Sci, Atlanta, GA 30329 USA
关键词
brain; drug abuse; mass spectrometry; neuronal; protein expression;
D O I
10.1023/B:NERE.0000023594.21352.17
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
As the technology of proteomics moves from a theoretical approach to a practical reality, neuroscientists will have to determine the most appropriate applications for this technology. Neuroscientists will have to surmount difficulties particular to their research, such as limited sample amounts, heterogeneous cellular compositions in samples, and the fact that many proteins of interest are rare, hydrophobic proteins. This review examines protein isolation and protein fractionation and separation using two-dimensional electrophoresis (2-DE) and mass spectrometry proteomic methods. Methods for quantifying relative protein expression between samples (e. g., 2-DIGE, and ICAT) are also described. The coverage of the proteome, ability to detect membrane proteins, resource requirements, and quantitative reliability of different approaches is also discussed. Although there are many challenges in proteomic neuroscience, this field promises many rewards in the future.
引用
收藏
页码:1065 / 1081
页数:17
相关论文
共 125 条
[71]  
Pánek J, 1999, ELECTROPHORESIS, V20, P3483, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3483::AID-ELPS3483>3.3.CO
[72]  
2-I
[73]  
Pappin Darryl J C, 2003, Methods Mol Biol, V211, P211
[74]   Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front [J].
Paweletz, CP ;
Charboneau, L ;
Bichsel, VE ;
Simone, NL ;
Chen, T ;
Gillespie, JW ;
Emmert-Buck, MR ;
Roth, MJ ;
Petricoin, EF ;
Liotta, LA .
ONCOGENE, 2001, 20 (16) :1981-1989
[75]  
Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO
[76]  
2-2
[77]   Clinical proteomics: Translating benchside promise into bedside reality [J].
Petricoin, EF ;
Zoon, KC ;
Kohn, EC ;
Barrett, JC ;
Liotta, LA .
NATURE REVIEWS DRUG DISCOVERY, 2002, 1 (09) :683-695
[78]   Optimization of protein precipitation based upon effectiveness of protein removal and ionization effect in liquid chromatography-tandem mass spectrometry [J].
Polson, C ;
Sarkar, P ;
Incledon, B ;
Raguvaran, V ;
Grant, R .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2003, 785 (02) :263-275
[79]   High-performance liquid chromatography-electrospray ionization mass spectrometry using monolithic capillary columns for proteomic studies [J].
Premstaller, A ;
Oberacher, H ;
Walcher, W ;
Timperio, AM ;
Zolla, L ;
Chervet, JP ;
Cavusoglu, N ;
van Dorsselaer, A ;
Huber, CG .
ANALYTICAL CHEMISTRY, 2001, 73 (11) :2390-+
[80]   Detecting proteins separated by 2-D gel electrophoresis [J].
Rabilloud, T .
ANALYTICAL CHEMISTRY, 2000, 72 (01) :48A-55A